Filing Details
- Accession Number:
- 0001562180-25-004346
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-03 16:30:28
- Reporting Period:
- 2025-06-02
- Filing Date:
- 2025-06-03
- Accepted Time:
- 2025-06-03 16:30:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1636178 | James Edgemond | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | Cfo And Treasurer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-06-02 | 12,000 | $117.76 | 20,118 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-06-02 | 2,603 | $325.54 | 17,515 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-06-02 | 1,397 | $326.34 | 16,118 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-06-02 | 5,347 | $325.59 | 10,771 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-06-02 | 2,653 | $326.31 | 8,118 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2025-06-02 | 12,000 | $0.00 | 12,000 | $117.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 99,500 | 2021-03-15 | 2027-03-15 | No | 4 | M | Direct |
Footnotes
- This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on November 6, 2024.
- Includes 50 shares of common stock acquired on March 4, 2025 under the United Therapeutics Employee Stock Purchase Plan.
- This transaction was executed in multiple trades at prices ranging from $325.00 to $325.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder ofthe issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $326.00 to $326.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder ofthe issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
